BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23610781)

  • 1. Leukemic phase of ALK-positive anaplastic large cell lymphoma.
    He R; Viswanatha DS
    Blood; 2013 Mar; 121(11):1934. PubMed ID: 23610781
    [No Abstract]   [Full Text] [Related]  

  • 2. ALK-negative anaplastic large cell lymphoma with JAK2 rearrangement mimicking classic Hodgkin lymphoma.
    Jaye DL; Feldman AL
    Blood; 2023 Apr; 141(17):2160. PubMed ID: 37103947
    [No Abstract]   [Full Text] [Related]  

  • 3. Progress in the identification of subgroups in ALK-negative anaplastic large-cell lymphoma.
    Boddicker RL; Feldman AL
    Biomark Med; 2015; 9(8):719-22. PubMed ID: 26223379
    [No Abstract]   [Full Text] [Related]  

  • 4. ALK Positive Anaplastic Large Cell Lymphoma With Pure Leptomeningeal Involvement: Unique Case Report and Review of the Literature.
    Bricker PC; Lesley WS; Surapaneni R
    Clin Neuroradiol; 2015 Jun; 25(2):177-9. PubMed ID: 24407988
    [No Abstract]   [Full Text] [Related]  

  • 5. Small-cell variant of ALK+ anaplastic large-cell lymphoma with a leukemic phase.
    Liu H; Hussein S
    Blood; 2014 Nov; 124(20):3175. PubMed ID: 25551161
    [No Abstract]   [Full Text] [Related]  

  • 6. ALK-positive anaplastic large-cell lymphoma with marked leukemoid reaction and hemophagocytic lymphohistiocytosis.
    Li W; Repnikova E
    Blood; 2016 Apr; 127(16):2041. PubMed ID: 27563714
    [No Abstract]   [Full Text] [Related]  

  • 7. Leukemic presentation of ALK-negative anaplastic large cell lymphoma in a patient with myelodysplastic syndrome.
    Tanaka H; Ohwada C; Hashimoto S; Sakai S; Takeda Y; Abe D; Takagi T; Ohshima K; Nakaseko C
    Intern Med; 2012; 51(2):199-203. PubMed ID: 22246491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetics of anaplastic large cell lymphoma.
    Zeng Y; Feldman AL
    Leuk Lymphoma; 2016; 57(1):21-7. PubMed ID: 26104084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ALK-negative anaplastic large cell lymphoma in leukemic phase with near-pentaploidy.
    Wong WS; Liu BW; Lam FS; Wong KF
    Leuk Lymphoma; 2010 Oct; 51(10):1927-30. PubMed ID: 20846102
    [No Abstract]   [Full Text] [Related]  

  • 10. Leukemic phase of anaplastic lymphoma kinase positive, anaplastic large cell lymphoma.
    Gadage VS; Subramanian PG; Galani KS; Sehgal KK; Johari SP; Ghogale VS; Badrinath Y; Ashok K; Gujral S
    Indian J Pathol Microbiol; 2011; 54(3):599-602. PubMed ID: 21934233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ALK-positive anaplastic large cell lymphoma with TPM3-ALK translocation.
    Shin S; Kim J; Yoon SO; Kim YR; Lee KA
    Leuk Res; 2012 Jul; 36(7):e143-5. PubMed ID: 22591683
    [No Abstract]   [Full Text] [Related]  

  • 12. Primary Gastric ALK-negative EBV-negative Anaplastic Large Cell Lymphoma Presenting with Iron Deficiency Anemia.
    Zhang W; Burton S; Wu S; Qian X; Rajeh MN; Schroeder K; Shuldberg M; Merando A; Lai JP
    In Vivo; 2017; 31(4):701-704. PubMed ID: 28652442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleophosmin-anaplastic lymphoma kinase: the ultimate oncogene and therapeutic target.
    Werner MT; Zhao C; Zhang Q; Wasik MA
    Blood; 2017 Feb; 129(7):823-831. PubMed ID: 27879258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma with the variant RNF213-, ATIC- and TPM3-ALK fusions is characterized by copy number gain of the rearranged ALK gene.
    van der Krogt JA; Bempt MV; Ferreiro JF; Mentens N; Jacobs K; Pluys U; Doms K; Geerdens E; Uyttebroeck A; Pierre P; Michaux L; Devos T; Vandenberghe P; Tousseyn T; Cools J; Wlodarska I
    Haematologica; 2017 Sep; 102(9):1605-1616. PubMed ID: 28659337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma: current and future perspectives in adult and paediatric disease.
    Eyre TA; Khan D; Hall GW; Collins GP
    Eur J Haematol; 2014 Dec; 93(6):455-68. PubMed ID: 24766435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refractory hemophagocytic lymphohistiocytosis in an adult patient with occult ALK-Positive anaplastic large cell lymphoma and a heterozygous MEFV mutation.
    Tariq H; Pearse W; Moravek MR; Gao J; Chen YH; Chen QC
    Leuk Lymphoma; 2022 Feb; 63(2):495-498. PubMed ID: 34612144
    [No Abstract]   [Full Text] [Related]  

  • 17. Advances in understanding the pathogenesis of systemic anaplastic large cell lymphomas.
    Boi M; Zucca E; Inghirami G; Bertoni F
    Br J Haematol; 2015 Mar; 168(6):771-83. PubMed ID: 25559471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New avenues for targeted therapies and biomarkers in anaplastic large cell lymphoma.
    Egger G; Turner SD
    Epigenomics; 2017 Feb; 9(2):97-100. PubMed ID: 28097892
    [No Abstract]   [Full Text] [Related]  

  • 19. Variant translocation partners of the anaplastic lymphoma kinase (ALK) gene in two cases of anaplastic large cell lymphoma, identified by inverse cDNA polymerase chain reaction.
    Takeoka K; Okumura A; Honjo G; Ohno H
    J Clin Exp Hematop; 2014; 54(3):225-35. PubMed ID: 25501114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ALK-positive anaplastic large cell lymphoma presenting with hemophagocytic lymphohistiocytosis.
    Shah M; Karnik L; Nadal-MelsiĆ³ E; Reid A; Ahmad R; Bain BJ
    Am J Hematol; 2015 Aug; 90(8):746. PubMed ID: 26114236
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.